MIRA INFORM REPORT

 

 

Report No. :

496425

Report Date :

07.03.2018

 

 

 

IDENTIFICATION DETAILS

 

Name :

TAIWAN PROSPERITY CHEMICAL CORPORATION

 

 

Registered Office :

9FL., No. 113, Sec. 2, Chung-Shan N. Rd., Taipei 104, R.O.C.

 

 

Country :

Taiwan

 

 

Financials (as on) :

31.12.2016

 

 

Date of Incorporation :

28.05.1991

 

 

Com. Reg. No.:

86120031

 

 

Legal Form :

Joint Stock Company

 

 

Line of Business :

Subject is engaged in manufacturing of chemicals.

 

 

No. of Employees :

178

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A

 

Credit Rating

Explanation

Rating Comments

A

Acceptable Risk

Business dealings permissible with moderate risk of default

 

Status :

Satisfactory

 

 

Payment Behaviour :

Slow but Correct

 

 

Litigation :

Clear

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(30.09.2017)

Current Rating

(31.12.2017)

Taiwan

A1

A1

 

Risk Category

ECGC

Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 


 

TAIWAN - ECONOMIC OVERVIEW

 

Taiwan has a dynamic capitalist economy that is driven largely by industrial manufacturing, and especially exports of electronics, machinery, and petrochemicals. This heavy dependence on exports exposes the economy to fluctuations in global demand. Taiwan's diplomatic isolation, low birth rate, rapidly aging population, and increasing competition from China and other Asia Pacific markets are other major long-term challenges.

Following the landmark Economic Cooperation Framework Agreement (ECFA) signed with China in June 2010, Taiwan in July 2013 signed a free trade deal with New Zealand - Taipei’s first-ever with a country with which it does not maintain diplomatic relations - and, in November of that year, inked a trade pact with Singapore. However, follow-on components of the ECFA, including a signed agreement on trade in services and negotiations on trade in goods and dispute resolution, have stalled. In early 2014, the government bowed to public demand and proposed a new law governing the oversight of cross-Strait agreements, before any additional deals with China are implemented; the legislature has yet to vote on such legislation, leaving the future of ECFA uncertain. President TSAI since taking office in May 2016 has promoted greater economic integration with South and Southeast Asia through the New Southbound Policy initiative and has also expressed interest in Taiwan joining the Trans-Pacific Partnership as well as bilateral trade deals with partners such as the US.

Taiwan's total fertility rate of just over one child per woman is among the lowest in the world, raising the prospect of future labor shortages, falling domestic demand, and declining tax revenues. Taiwan's population is aging quickly, with the number of people over 65 expected to account for nearly 20% of the island's total population by 2025.

The island runs a trade surplus with many economies, including China and the US, and its foreign reserves are the world's fifth largest, behind those of China, Japan, Saudi Arabia, and Switzerland. In 2006, China overtook the US to become Taiwan's second-largest source of imports after Japan. China is also the island's number one destination for foreign direct investment. Taiwan since 2009 has gradually loosened rules governing Chinese investment and has also secured greater market access for its investors on the mainland. In August 2012, the Taiwan Central Bank signed a memorandum of understanding (MOU) on cross-Strait currency settlement with its Chinese counterpart. The MOU allows for the direct settlement of Chinese renminbi (RMB) and the New Taiwan dollar across the Strait, which has helped Taiwan develop into a local RMB hub.

Closer economic links with the mainland bring opportunities for Taiwan’s economy but also pose challenges as political differences remain unresolved and China’s economic growth is slowing. Domestic economic issues loomed large in public debate ahead of the January 2016 presidential and legislative elections, including concerns about stagnant wages, high housing prices, youth unemployment, job security, and financial security in retirement.

 

Source : CIA

 


Company Name AND Address:

 

Company Name:

Taiwan Prosperity Chemical Corporation

Supplied Name:

TAIWAN PROSPERITY CHEMICAL CORPORATION

Trading Address:

9FL., No. 113, Sec. 2, Chung-Shan N. Rd., Taipei 104, Taiwan, R.O.C.

Supplied Address:

FLOOR 9, NO.113 CHUNG-SHAN NORTH ROAD SEC 2, TAIPEI 104- TAIWAN

Telephone Number:

+886-2-2563-3228

Fax Number:

+886-2-2563-5181

E-mail:

business@tpcc.com.tw

Website:

www.tpcc.com.tw

 

Notes: Subject’s exact name and address are as above.

 

 

Company Identification Details

 

Registered Name:

Taiwan Prosperity Chemical Corporation

Registered Address:

9FL., No. 113, Sec. 2, Chung-Shan N. Rd., Taipei 104, Taiwan, R.O.C.

Date of Foundation:

1991-05-28

Registration Number:

86120031

Registry:

Department of Commerce, Ministry of Economic Affairs, R.O.C.

Registered Capital:

NTD 4,000,000,000 (USD 132,800,000)

(As of 2017.11, 1 NTD = 0.0332 USD) 

Paid-up Capital:

NTD 2,919,750,000 (USD 96,935,700)

Legal Representatives:

Anping Zhang

Legal Form:

Joint Stock Company

Principal Activities:

Manufacturing and sales of chemicals.

Staff:

About 178 Employees

(As of 2017-5-12)

Listed at Stock Exchange:

Yes, Stock Symbol: 4725

Date of Last Annual Return:

2017-2-3

 

 

History

 

Subject was incorporated on 1991-05-28 with registered number 86120031 as Joint Stock Company in Taiwan.

Subject was listed on Taiwan Stock Exchange on 2007-10-02.

 

 

Corporate Structure

 

Factory

Name:

Linyuan Factory

Address:

No. 9, Gongye 3rd Rd., Linyuan Industrial Zone, Linyuan Township, Kaohsiung County, Taiwan

Date of Foundation:

1992-08-25

Date of Registration:

1995-10-16

Factory Registration Number:

99661829

Factory Manager:

Tianfu Zhao

Status:

In Production

Date of Last Annual Return:

2015-08-03

Major Products:

Petrochemical materials

 

Note: Subject has 6 plants on the above address for manufacturing of cumene, acetone, bisphenol, cyclohexanone and marin anhydride.

 

 

Shareholders

 

Major Shareholders

 

Name

Subscription Shares

Taiwan Cement Corporation

145,987,998

 

Shareholder Information:

Registered Name:

Taiwan Cement Corporation

Registered Address:

No. 113, Sec. 2, Chung Shan N. Rd., Taipei City, Taiwan, R.O.C.

Date of Foundation:

1950-12-29

Registration Number:

11913502

Registry:

Department of Commerce, Ministry of Economic Affairs, R.O.C.

Registered Capital:

NTD 40,073,866,000

Paid-up Capital:

NTD 36,921,758,690

Legal Representatives:

Anping Zhang

Legal Form:

Joint Stock Company

Listed at Stock Exchange:

Yes; Stock Code: 1101

Date of Last Annual Return:

2017-8-9

Telephone Number:

+886-2-2531-6533

Fax Number:

+886-2-2531-6529

 


Management Information

 

Core Management

 

1

Name

Anping Zhang

Position

Board Chairman

2

Name

Gongyi Gu

Position

Director

3

Name

Jiye Chen

Position

Director

4

Name

Fulong Chen

Position

Director

5

Name

Renhe Jiao

Position

Independent Director

6

Name

Zhiren Sheng

Position

Independent Director

7

Name

Zinan Jia

Position

Independent Director

8

Name

Tianfu Zhao

Position

Manager

Dare of Appointment

2012-04-02

 

 

Personnel Structure

 

Total Employees

About 164 Employees (As of 2016-6-30)

 

 

Operation Information

 

Offices & Factories

 

 

Headquarters

Add

9FL., No.113, Sec. 2, Chung-Shan N. Rd., Taipei 104, Taiwan, R.O.C.

 

Production Information

 

Subject is engaged in manufacturing of chemicals and etc.

It is introduced that subject has 6 factories in Linyuan Township, Kaohsiung County, Taiwan for production. (Total area is about 13 hectare)

Subject obtained the certifications of ISO 9002, ISO 14001, etc.

 

Purchase Information

 

The registered activities of subject:

Business Code

Details

C801020

Manufacture of petrochemical materials

F107200

Wholesales of chemical materials

F107990

Wholesales of other chemical products

F207200

Retails of chemical materials

F207990

Retails of other chemical products

ZZ99999

Besides licensed business, all other business items those are not banned or restricted.

 

The raw materials and etc are purchased both at home and abroad.

It is introduced that subject import some raw materials from some Asian countries, etc.

It is introduced that subject imports some technology from USA.

It is introduced that subject has many suppliers such as apex, trammo, SK, CPC Corporation, Mitsubishi Group, Marubeni Corporation, Mitsui Group and etc.

 

Sales Information

 

Subject is engaged in sale of chemicals, etc.

The major products of subject are petrochemical intermediate materials, including of isopropyl benzene, phenol, acetone, bisphenol, cyclohexanone and malic anhydride, etc.

It is introduced that subject’s products are applied in the manufacturing of phenol, acetone, phenolic resins, salicylic acid, organic solvents, epoxide resins, flame retardants, vibrins and organic solvents.

Subject’s sales regions cover China, India, America, North Asia, Southeast Asia, China and Middle East, etc.

Subject’s major customers are chemical industry, plastic industry and etc.

It is introduced that subject has many customers such as ICC Chemical Corporation, BASF Chile S.A., Micro Inks Ltd., China Petroleum & Chemical, Kaohsiung Monomer Company Ltd, and Chimei Asahi Corporation, etc.

It is introduced that the companies named Formosa Chemicals & Fibre Corporation and Chang Chung Group are subject’s major competitors in Taiwan.

 

Import and export right:

Import right

Yes

Export right

Yes

 

 

Settlements

 

PURCHASE

 

Domestic Purchase

Products

Raw materials, etc.

Payment Terms

T/T, Cash, etc.

Import

Products

Raw materials, etc.

Payment Terms

L/C, T/T, etc.

 

SALES

 

Domestic Markets

Product

Chemicals, etc.

Selling Terms

T/T, Cash, etc.

 

 

Export

Product

Chemicals, etc.

Selling Terms

L/C, T/T, etc.

 

 

Balance Sheet

 

Unit: NTD/000

 

Consolidated

2016-12-31

2015-12-31

Assets

 

 

Current assets

 

 

Cash and cash equivalents

 

 

Total cash and cash equivalents

355,734

316,100

Current available-for-sale financial assets

 

 

Current available-for-sale financial assets, net

832,703

750,190

Accounts receivable, net

 

 

Accounts receivable, net

1,300,559

966,462

Other receivables

 

 

Other receivables, net

27,475

48,688

Inventories

 

 

Total inventories

618,429

903,116

Prepayments

 

 

Total prepayments

79,146

111,525

Other current assets

 

 

Total other current assets

2,651

2,891

Total current assets

3,216,697

3,098,972

Non-current assets

 

 

Property, plant and equipment

 

 

Total property, plant and equipment

7,076,593

7,515,974

Deferred tax assets

276,745

287,267

Other non-current assets

 

 

Other non-current assets, others

 

 

Total other non-current assets, others

651,989

750,665

Total other non-current assets

651,989

750,665

Total non-current assets

8,005,327

8,553,906

Total assets

11,222,024

11,652,878

Liabilities and equity

 

 

Liabilities

 

 

Current liabilities

 

 

Short-term borrowings

 

 

Total short-term borrowings

1,690,911

1,290,000

Short-term notes and bills payable

 

 

Total short-term notes and bills payable

399,674

599,182

Accounts payable

 

 

Total accounts payable

828,232

614,395

Other payables

 

 

Total other payables

612,159

555,402

Other current liabilities

 

 

Long-term liabilities, current portion

 

 

Total long-term liabilities, current portion

570,000

285,000

Other current liabilities, others

17,037

15,267

Total other current liabilities

587,037

300,267

Total current liabilities

4,118,013

3,359,246

Non-current liabilities

 

 

Long-term borrowings

 

 

Total long-term borrowings

1,745,000

2,315,000

Other non-current liabilities

 

 

Long-term notes and accounts payable to related parties

 

 

Long-term lease obligations payable to related parties

1,858,437

2,108,860

Total long-term notes and accounts payable to related parties

1,858,437

2,108,860

Other non-current liabilities, others

94,428

129,711

Total other non-current liabilities

1,952,865

2,238,571

Total non-current liabilities

3,697,865

4,553,571

Total liabilities

7,815,878

7,912,817

Equity

 

 

Share capital

 

 

Ordinary share

2,919,750

2,919,750

Total capital stock

2,919,750

2,919,750

Capital surplus

 

 

Total capital surplus

690,000

690,000

Retained earnings

 

 

Legal reserve

192,858

1,287,784

Unappropriated retained earnings (accumulated deficit)

 

 

Total unappropriated retained earnings (accumulated deficit)

-416,428

-1,094,926

Total retained earnings

-223,570

192,858

Other equity interest

 

 

Unrealized gains (losses) on available-for-sale financial assets

 

 

Total unrealized gains (losses) on available-for-sale financial assets

19,966

-62,547

Total other equity interest

19,966

-62,547

Total equity

3,406,146

3,740,061

Total liabilities and equity

11,222,024

11,652,878

Equivalent issue shares of advance receipts for ordinary share

0

0

Number of shares in entity held by entity and by its subsidiaries

0

0

 

 

Profit and Loss Account

 

Unit: NTD/000

Consolidated

2016

2015

Operating revenue

 

 

Net sales revenue

 

 

Net sales revenue

9,786,811

11,741,599

Total operating revenue

9,786,811

11,741,599

Operating costs

 

 

Cost of sales

 

 

Total cost of sales

9,715,797

13,008,053

Total operating costs

9,715,797

13,008,053

Gross profit (loss) from operations

71,014

-1,266,454

Gross profit (loss) from operations

71,014

-1,266,454

Operating expenses

 

 

Selling expenses

 

 

Total selling expenses

239,675

311,488

Administrative expenses

 

 

Total administrative expenses

42,644

53,669

Research and development expenses

 

 

Total research and development expenses

20,618

6,895

Total operating expenses

302,937

372,052

Net operating income (loss)

-231,923

-1,638,506

Non-operating income and expenses

 

 

Other gains and losses

 

 

Other gains and losses, net

13,095

-13,741

Finance costs

 

 

Finance costs, net

187,342

196,849

Total non-operating income and expenses

-174,247

-210,590

Profit (loss) from continuing operations before tax

-406,170

-1,849,096

Tax expense (income)

 

 

Total tax expense (income)

10,075

13,876

Profit (loss) from continuing operations

-416,245

-1,862,972

Profit (loss)

-416,245

-1,862,972

Other comprehensive income

 

 

Components of other comprehensive income that will not be reclassified to profit or loss

 

 

Gains (losses) on remeasurements of defined benefit plans

-220

-2,104

Income tax related to components of other comprehensive income that will not be reclassified to profit or loss

-37

-358

Components of other comprehensive income that will not be reclassified to profit or loss

-183

-1,746

Components of other comprehensive income that will be reclassified to profit or loss

 

 

Unrealised gains (losses) on valuation of available-for-sale financial assets

82,513

-108,580

Components of other comprehensive income that will be reclassified to profit or loss

82,513

-108,580

Other comprehensive income, net

82,330

-110,326

Total comprehensive income

-333,915

-1,973,298

Basic earnings per share

 

 

Basic earnings (loss) per share from continuing operations

-1.43

-6.38

Total basic earnings per share

-1.43

-6.38

Diluted earnings per share

 

 

Diluted earnings (loss) per share from continuing operations

-1.43

-6.38

Total diluted earnings per share

-1.43

-6.38

 

 

Cash Flows

 

Unit: NTD/000

Consolidated

2016

2015

Cash flows from (used in) operating activities, indirect method

 

 

Profit (loss) from continuing operations before tax

-406,170

-1,849,096

Profit (loss) before tax

-406,170

-1,849,096

Adjustments

 

 

Adjustments to reconcile profit (loss)

 

 

Depreciation expense

665,216

751,663

Interest expense

187,342

196,849

Interest income

-1,487

-1,595

Dividend income

-31,746

-6,581

Impairment loss on non-financial assets

3,541

-109,083

Unrealized foreign exchange loss (gain)

10,260

-5,835

Other adjustments to reconcile profit (loss)

3,217

4,295

Total adjustments to reconcile profit (loss)

836,343

829,713

Changes in operating assets and liabilities

 

 

Changes in operating assets

 

 

Decrease (increase) in accounts receivable

-333,167

775,525

Decrease (increase) in other receivable

21,269

20,709

Decrease (increase) in inventories

290,240

1,214,231

Decrease (increase) in prepayments

32,379

23,042

Decrease (increase) in other current assets

240

6,998

Total changes in operating assets

10,961

2,040,505

Changes in operating liabilities

 

 

Increase (decrease) in accounts payable

209,848

-213,500

Increase (decrease) in other payable

59,105

-62,361

Increase (decrease) in other current liabilities

1,770

7,906

Increase (decrease) in net defined benefit liability

-35,821

-17,727

Total changes in operating liabilities

234,902

-285,682

Total changes in operating assets and liabilities

245,863

1,754,823

Total adjustments

1,082,206

2,584,536

Cash inflow (outflow) generated from operations

676,036

735,440

Interest received

1,431

1,573

Interest paid

-62,557

-60,761

Net cash flows from (used in) operating activities

614,910

676,252

Cash flows from (used in) investing activities

 

 

Acquisition of property, plant and equipment

-112,261

-300,331

Dividends received

31,746

6,581

Other investing activities

-36,111

-76,002

Net cash flows from (used in) investing activities

-116,626

-369,752

Cash flows from (used in) financing activities

 

 

Increase in short-term loans

10,830,581

11,085,371

Decrease in short-term loans

-10,437,712

-11,312,535

Increase in short-term notes and bills payable

1,695,896

1,896,199

Decrease in short-term notes and bills payable

-1,900,000

-2,100,000

Proceeds from long-term debt

0

700,000

Repayments of long-term debt

-285,000

0

Decrease in lease payable

-360,000

-393,300

Increase in other non-current liabilities

-2,415

-6,273

Net cash flows from (used in) financing activities

-458,650

-130,538

Net increase (decrease) in cash and cash equivalents

39,634

175,962

Cash and cash equivalents at beginning of period

316,100

140,138

Cash and cash equivalents at end of period

355,734

316,100

Cash and cash equivalents reported in the statement of financial position

355,734

316,100

 

Note: Subject didn’t submit its individual financial information; we obtained its consolidated financials as follows for reference.

 

The above financial figures are based on the IFRSs Accounting System.

Bankers

 

Subject declined to disclose its bank details; from other source we could not obtain the relevant information, either.

 

 

Public Record

 

Mortgage

No chattel mortgage record of subject has been found within the recent 3 months.

 

Lawsuit

Up to date of reporting, no existing or latent litigation of the subject has been found.

 

 

Special Note

 

Interview Details

Name

Ms. Lin

Department

Sales Department

 

 

 

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

INR 64.99

UK Pound

1

INR 89.91

Euro

1

INR 80.21

TWD

1

INR 2.22

 

Note : Above are approximate rates obtained from sources believed to be correct

 

 

INFORMATION DETAILS

 

Analysis Done by :

PRI

 

 

Report Prepared by :

TRU

 


 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.